Clinical Trial Update: Feasibility of Screening for Early Late Effects of Contemporary Therapy in High-Risk Neuroblastoma Survivors

View source ↗

Summary

A clinical trial sponsored by St. Jude is evaluating the feasibility of screening for early late effects in survivors of high-risk neuroblastoma and is currentl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroblastoma

Snippet

Sponsor: St. Jude Children's Research Hospital | Conditions: High-risk Neuroblastoma | Status: RECRUITING